AGP Executive Report
Last update: 5 hours agoCancer Coverage Upgrade (Malaysia–China): Malaysian Re and China Re Life signed a treaty to create Malaysia’s first dedicated framework for advanced cancer precision medicine coverage, including CAR-T, targeted therapies and precision immunotherapy, with an overseas benefit for treatment at designated oncology centres in China. Clinical Trials Push (US–China): US health agencies unveiled “Operation Trial Blazer” to speed up phase 1 trials by 6–12 months and encourage more studies in the US rather than faster overseas sites. ENT Breakthrough (Malaysia): Johor Specialist Hospital performed Malaysia’s first awake mastoid and eardrum repair under local anaesthesia, aiming to reduce risks for elderly patients who may face extra considerations with general anaesthesia. Foreign Investment & Health Access (China): China released a plan to stabilise foreign investment, expanding market access in services including finance and pharmaceuticals, and streamlining procedures for cross-border deals. Public Health & Safety (India): A coaching centre fire in Lucknow killed at least 14, with officials citing asphyxiation for many deaths and promising action against those responsible. Wellness Market Signals: Danone moves to strengthen its Asia-Pacific beverages portfolio via an acquisition, while tea trends in India show rising demand for functional and “healthier” varieties like tulsi/green/blue pea and kombucha.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
